OBJECTIVES The aim of this study was to evaluate the utility of transesophageal echocardiography (TEE) during transvenous lead extraction (TLE) involving both conventional and laser lead removal.
T ransvenous lead extraction (TLE) is being performed in greater numbers of patients each year as the number of pacemakers and implantable cardioverter-defibrillators (ICDs) implanted increases. Despite relatively low major complication (0.4% to 3.4%) (1) (2) (3) (4) and mortality (0.00% to 1.86%) rates (1, 2, 4) , the risk of serious adverse events remains due to vascular laceration, and great care is needed to both prevent and respond to such events.
Despite the inherent risk, many lead extractions are performed in the electrophysiology laboratory with cardiothoracic surgeons "on standby" (5) . One study comparing procedures performed in the electrophysiology laboratory with those performed in the operating room found no difference in complication or mortality rate between the two (6) . Although current guidelines do not require that this procedure be performed in an operating room, there is a strong recommendation for immediately available cardiothoracic surgery backup on the basis of previous findings that delays in open access to the heart of more than 5 to 10 min often result in fatal outcomes (7) .
There is also no clear consensus on the use of echocardiography during TLE. Current recommendations suggest transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) be immediately available, but no recommendation is made for monitoring with TEE (7) . This modality has previously shown benefit before and after TLE as well as being of benefit as an intraprocedural monitoring tool (1, 8) .
Proposed benefits include evaluation of lead vegetations before attempted TLE, investigation of causes of intraprocedural hypotension, and rapid detection and localization of cardiac defects caused by TLE itself.
Although previous case reviews have examined the role of continuous TEE, predominantly in patients undergoing conventional TLE, there are few data on its utility in laser lead extraction (1, 9) . Here we seek to review patients undergoing both conventional and laser TLE with continuous TEE monitoring. Heart Rhythm Society Guidelines on transvenous lead extraction, pocket infection was defined as "erythema with or without purulent discharge, device erosion, fat necrosis, and/or adherence of device to the skin" (10) . All other infections were considered device-related endocarditis, and, of note, all such patients had positive blood cultures.
PROCEDURE. All TLE procedures were performed in a hybrid operating room by a cardiac electrophysiologist with a cardiothoracic surgeon present during the procedure. After induction of general anesthesia by a cardiac anesthesiologist who was certified for perioperative TEE, an arterial line was placed in the radial artery, and a TEE probe was inserted in the midesophagus. A stepwise approach was used for TLE beginning with simple traction, 
RESULTS

DEMOGRAPHICS AND INDICATIONS FOR EXTRACTION.
Baseline characteristics and indications for TLE are listed in Table 1 . Sixty-seven patients were male, and the average age of all patients was 57 AE 17 years. In 
Oestreich et al. There were 8 patients who experienced significant hypotension during the procedure (systolic blood pressure <90 mm Hg). Four of these patients had no obvious cause for hypotension seen on TEE, and the procedure was allowed to continue without premature termination. Right ventricular inversion was observed in 4 of these patients, as shown in Figure 1 , and allowed the operator to decrease the traction on the lead, improve blood pressure, and continue with the procedure.
The average length of hospital stay was 7.37 days (range 1 to 37 days). In-hospital mortality rate for all 100 patients was 0%. Coronary sinus lead 20
Epicardial lead 1
Defibrillator lead 81
Method of extraction, %
Manual traction 20
Laser 80
Values are average AE SD unless otherwise indicated.
Oestreich et al.
right atrium (5 masses). There were no cases of clinical pulmonary embolism after device extraction in these patients ( Table 3) . 
Oestreich et al. Continuous TEE may be useful in the evaluation of intracardiac masses and may assist in management Oestreich et al. In our review, intraprocedural hypotension developed in 8 patients. In 4 of these patients, no cardiac structural damage or pericardial effusion was identified, allowing for continuation of the procedure without unnecessary delays or premature termination.
TEE does not come without its own inherent risks.
In our review, 1 patient (1%) had a complication attributed to TEE itself in the form of an upper GI bleed several hours after the procedure. and a reduction in the need for postoperative studies (17, 18) . We are unable to extrapolate these data to TLE given its obvious differences, and further studies are needed to evaluate whether TEE for TLE is costeffective.
Our results are consistent with those of previous studies that examined the utility of TEE in patients primarily undergoing TLE (1,9). Our patient population comprised predominantly patients requiring laser lead removal, and a majority of the leads extracted were ICD leads. The rates of both procedural success and major complications were similar to those of previous investigations (1, 2, 6, 19) .
Compared with the study reported by Regoli et al. 
